BiotechTube

Balovaptan + Placebo

Phase 2Completed
1 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Stress Disorders, Post-Traumatic

Conditions

Stress Disorders, Post-Traumatic

Trial Timeline

Aug 2, 2022 → Oct 5, 2023

NCT ID
NCT05401565

About Balovaptan + Placebo

Balovaptan + Placebo is a phase 2 stage product being developed by Roche for Stress Disorders, Post-Traumatic. The current trial status is completed. This product is registered under clinical trial identifier NCT05401565. Target conditions include Stress Disorders, Post-Traumatic.

What happened to similar drugs?

8 of 20 similar drugs in Stress Disorders, Post-Traumatic were approved

Approved (8) Terminated (1) Active (12)
✅solifenacinAstellas PharmaApproved
✅duloxetine HClEli LillyApproved
✅Duloxetine hydrochloride + placeboEli LillyApproved
✅Minocycline + PlaceboJohnson & JohnsonApproved
✅Placebo + sertralineJohnson & JohnsonApproved
✅Adjunctive asenapineMerckApproved
✅ZiprasidonePfizerApproved

Hype Score Breakdown

Clinical
12
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (3)

NCT IDPhaseStatus
NCT05401565Phase 2Completed
NCT05399550Phase 2Withdrawn
NCT03504917Phase 3Terminated

Competing Products

20 competing products in Stress Disorders, Post-Traumatic

See all competitors
ProductCompanyStageHype Score
Duloxetine + placeboEli LillyPhase 2
35
agenT-797MiNK TherapeuticsPhase 1
19
Thermal stress and performance without a pre-cooling protocolPetros PharmaceuticalsPre-clinical
16
solifenacinAstellas PharmaApproved
43
SivelestatEli LillyPhase 1/2
32
Duloxetine + PlaceboEli LillyPhase 3
40
DuloxetineEli LillyPhase 3
40
Duloxetine + PlaceboEli LillyPhase 3
40
DuloxetineEli LillyPhase 3
40
Duloxetine hydrochlorideEli LillyPhase 3
36
DuloxetineEli LillyPhase 3
40
duloxetine + PlaceboEli LillyPhase 2
35
Exenatide + InsulinEli LillyPhase 2/3
38
DuloxetineEli LillyPhase 3
40
duloxetine HClEli LillyApproved
43
Orforglipron + PlaceboEli LillyPhase 3
47
Duloxetine hydrochloride + placeboEli LillyApproved
43
Duloxetine + PlaceboEli LillyPhase 3
40
duloxetine + placeboEli LillyPhase 3
40
DuloxetineEli LillyPhase 3
40